Literature DB >> 2043496

Topical treatment of epidemic Kaposi's sarcoma with all-trans-retinoic acid.

L Bonhomme, G Fredj, S Averous, A M Szekely, E Ecstein, B Trumbic, P Meyer, J M Lang, J L Misset, C Jasmin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2043496     DOI： 10.1093/oxfordjournals.annonc.a057916

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  6 in total

1.  Retinoid antagonism of NF-IL6: insight into the mechanism of antiproliferative effects of retinoids in Kaposi's sarcoma.

Authors:  S Nagpal; J Cai; T Zheng; S Patel; R Masood; G Y Lin; S Friant; A Johnson; D L Smith; R A Chandraratna; P S Gill
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

2.  Topical treatments for Kaposi sarcoma: A systematic review.

Authors:  Kyaw Zin Htet; Michael Andrew Waul; Kieron Seymour Leslie
Journal:  Skin Health Dis       Date:  2022-04-08

3.  Antiproliferative effect of retinoid compounds on Kaposi's sarcoma cells.

Authors:  J Corbeil; E Rapaport; D D Richman; D J Looney
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

4.  Retinoic acid mimics transforming growth factor beta in the regulation of human immunodeficiency virus expression in monocytic cells.

Authors:  G Poli; A L Kinter; J S Justement; P Bressler; J H Kehrl; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

Review 5.  Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults.

Authors:  Oluwatoyin F Gbabe; Charles I Okwundu; Martin Dedicoat; Esther E Freeman
Journal:  Cochrane Database Syst Rev       Date:  2014-08-13

6.  RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation.

Authors:  J Y Chen; S Penco; J Ostrowski; P Balaguer; M Pons; J E Starrett; P Reczek; P Chambon; H Gronemeyer
Journal:  EMBO J       Date:  1995-03-15       Impact factor: 11.598
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.